Catalyst Wire Dossier Catalyst Wire Dossier

Marzeptacog Alfa (Activated)

Marzeptacog alfa activated · Catalyst Biosciences
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Marzeptacog Alfa (Activated), covering 2021-07-16 to 2021-12-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or B [Phase 3]

See pricing